Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/02/22
Avidity Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Recent HighlightsPRNewsWire • 03/01/22
Avidity Biosciences Highlights FSHD Program at Virtual Investor and Analyst EventPRNewsWire • 12/09/21
Avidity Biosciences Reports Third Quarter 2021 Financial Results and Recent HighlightsPRNewsWire • 11/09/21
Earnings Preview: Avidity Biosciences, Inc. (RNA) Q3 Earnings Expected to DeclineZacks Investment Research • 11/02/21
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial UsePRNewsWire • 08/16/21
Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent HighlightsPRNewsWire • 08/09/21
Will Avidity Biosciences, Inc. (RNA) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/02/21
Avidity Biosciences Shares Gain As Its Oligonucleotide Candidate Enters Early-Stage Trial In Muscle Wasting DisorderBenzinga • 08/02/21
Avidity Biosciences Announces Updates on the Pipeline and Platform at Virtual Investor and Analyst EventPRNewsWire • 05/19/21
Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent HighlightsPRNewsWire • 05/12/21
Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent HighlightsPRNewsWire • 03/15/21
Avidity Biosciences to Present at the 39th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 12/22/20
U.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO WeekSeeking Alpha • 12/06/20
Avidity Biosciences Reports Third Quarter 2020 Financial Results and Recent HighlightsPRNewsWire • 11/10/20
Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020PRNewsWire • 09/28/20
Avidity Biosciences Enters into Collaboration to Study the Natural History of Myotonic Dystrophy Type 1PRNewsWire • 09/08/20